ArticleJAMA2021
Vitamin D3 to Treat COVID-19: Different Disease, Same Answer.
Article in JAMA, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.
- Vitamin D insufficiency is high in Malaysia: A systematic review and meta-analysis of studies on vitamin D status in Malaysia.Frontiers in nutrition · 2022Pooled it
- Trial
- High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: Multicentre randomized controlled clinical trial.PloS one · 2022Trial
- Beneficial effects of novel aureobasidium pullulans strains produced beta-1,3-1,6 glucans on interleukin-6 and D-dimer levels in COVID-19 patients; results of a randomized multiple-arm pilot clinical study.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022Trial
- COVID-19 management in patients with comorbid conditions.World journal of virology · 2025Review
- Vitamin D and COVID-19: Clinical Evidence and Immunological Insights.Life (Basel, Switzerland) · 2025Review
- Association of air pollution and weather conditions during infection course with COVID-19 case fatality rate in the United Kingdom.Scientific reports · 2024Article
- Vitamin D deficiency and duration of COVID-19 symptoms in UK healthcare workers.Frontiers in medicine · 2024Article
- Small molecule metabolites: discovery of biomarkers and therapeutic targets.Signal transduction and targeted therapy · 2023Review
- Therapeutic advances in COVID-19.Nature reviews. Nephrology · 2023Review
- Novel CYP11A1-Derived Vitamin D and Lumisterol Biometabolites for the Management of COVID-19.Nutrients · 2022Review
- COVID-19 and Vitamin D- a Systematic Review.Zdravstveno varstvo · 2022Article
- Vitamin D and COVID-19 Severity in Hospitalized Older Patients: Potential Benefit of Prehospital Vitamin D Supplementation.Nutrients · 2022Observational
- Clinical aspects of SARS-CoV-2 infection and vitamin D : COVID-19 and the endocrine system: special issue for reviews in endocrine and metabolic disorders (Felipe Casaneuva, Editor in Chief) A. Giustina and JP Bilezikian, Guest Editors.Reviews in endocrine & metabolic disorders · 2022Review
- Hallmarks of Severe COVID-19 Pathogenesis:Frontiers in immunology · 2022Review
- The effect ofFrontiers in pharmacology · 2022Article
- Current advancements and future prospects of COVID-19 vaccines and therapeutics: a narrative review.Therapeutic advances in vaccines and immunotherapy · 2022Review
- The Interaction of Vitamin D and Corticosteroids: A Mortality Analysis of 26,508 Veterans Who Tested Positive for SARS-CoV-2.International journal of environmental research and public health · 2021Article
- Vitamin D Supplementation Should Be Considered for the Treatment of COVID-19 Infection in Malaysia in View of the High Prevalence of Vitamin D Deficiency.The Malaysian journal of medical sciences : MJMS · 2021Article
- Learning from previous methodological pitfalls to propose well-designed trials on vitamin D in COVID-19.The Journal of steroid biochemistry and molecular biology · 2021Article
Corrections and comments
- Comment on
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.